(RVMD) Revolution Medicines - Performance 4.7% in 12m
Compare RVMD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
13.21%
#29 in Group
Rel. Strength
48.69%
#4094 in Universe
Total Return 12m
4.69%
#51 in Group
Total Return 5y
38.70%
#32 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -11.23%
(?) Percentile in Group
12m Total Return: RVMD (4.7%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: RVMD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RVMD
Total Return (including Dividends) | RVMD | XBI | S&P 500 |
---|---|---|---|
1 Month | 20.88% | 5.55% | -0.45% |
3 Months | -3.56% | -9.75% | -6.29% |
12 Months | 4.69% | -5.39% | 13.04% |
5 Years | 38.70% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | RVMD | XBI | S&P 500 |
1 Month | 94.8% | 70% | 47.5% |
3 Months | -69.4% | -88.1% | -87.3% |
12 Months | -10.5% | -44.4% | 54.3% |
5 Years | 17.1% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #46 | 14.5% | 21.4% |
3 Month | #65 | 6.86% | 2.92% |
12 Month | #51 | 10.7% | -7.39% |
5 Years | #32 | 59.8% | -34.5% |
FAQs
Does RVMD Revolution Medicines outperforms the market?
Yes,
over the last 12 months RVMD made 4.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months RVMD made -3.56%, while XBI made -9.75%.
Over the last 3 months RVMD made -3.56%, while XBI made -9.75%.
Performance Comparison RVMD vs Indeces and Sectors
RVMD vs. Indices RVMD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.19% | 21.3% | -24.7% | -8.35% |
US NASDAQ 100 | QQQ | 2.27% | 19.0% | -25.4% | -10.3% |
US Dow Jones Industrial 30 | DIA | 3.73% | 23.7% | -23.9% | -4.58% |
German DAX 40 | DAX | 3.55% | 21.1% | -42.7% | -20.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.84% | 24.1% | -21.0% | -0.28% |
Hongkong Hang Seng | HSI | 3.59% | 22.4% | -25.2% | -8.24% |
India NIFTY 50 | INDA | 5.71% | 16.0% | -24.5% | 1.79% |
Brasil Bovespa | EWZ | 4.82% | 18.1% | -30.4% | 11.4% |
RVMD vs. Sectors RVMD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.04% | 21.5% | -30.6% | -18.8% |
Consumer Discretionary | XLY | 3.16% | 21.5% | -25.8% | -9.98% |
Consumer Staples | XLP | 5.25% | 21.7% | -28.8% | -6.25% |
Energy | XLE | 7.45% | 34.9% | -19.5% | 14.0% |
Financial | XLF | 4.30% | 22.9% | -31.6% | -18.0% |
Health Care | XLV | 5.89% | 25.6% | -19.5% | 5.92% |
Industrial | XLI | 2.87% | 20.6% | -25.7% | -6.00% |
Materials | XLB | 5.0% | 24.1% | -16.8% | 9.13% |
Real Estate | XLRE | 3.30% | 22.0% | -24.8% | -13.7% |
Technology | XLK | 1.63% | 18.5% | -21.7% | -5.75% |
Utilities | XLU | 4.47% | 20.8% | -29.1% | -16.1% |
Aerospace & Defense | XAR | 2.16% | 13.9% | -38.5% | -22.8% |
Biotech | XBI | 3.35% | 15.3% | -9.34% | 10.1% |
Homebuilder | XHB | 4.46% | 23.0% | -9.69% | 10.9% |
Retail | XRT | 4.43% | 22.0% | -18.7% | 6.20% |